Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2017 Filed Aug 15, 2017 19:03 UTC |
Williams R SandersDirector
|
SaleCommon Stock | 200 | $156.68 | $31,336.26 |
DisclosureSEC source: 0001127602-17-025632 · form4.xml · nonDerivative · entry 2 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,873 Read SEC document |
| August 11, 2017 Filed Aug 15, 2017 19:03 UTC |
Williams R SandersDirector
|
Exercise / conversionCommon Stock | 3,100 | $77.19 | $239,289.00 |
DisclosureSEC source: 0001127602-17-025632 · form4.xml · nonDerivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2017 Filed Sep 7, 2017 13:18 UTC |
KING DAVID PDirector · President & CEO
|
GiftCommon Stock | 1,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-027117 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,065.582 F1 · balance_after: Amount includes 156.9666 shares acquired on June 30, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan and annuity payments from each of the reporting person's grantor retained annuity trusts to the reporting person in the amounts and on the dates indicated in notes 4 and 5 below. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 20:35 UTC |
Dodson Edward TPrincipal Accounting Officer
|
SaleCommon Stock | 2,671 | $160.13 | $427,713.91 |
DisclosureSEC source: 0001127602-17-024876 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,031.1124 F1 · balance_after: Amount includes 148.5275 shares acquired on June 30, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 20:35 UTC |
Dodson Edward TPrincipal Accounting Officer
|
SaleCommon Stock | 200 | $160.13 | $32,025.00 |
DisclosureSEC source: 0001127602-17-024876 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,702.1124 F1 · balance_after: Amount includes 148.5275 shares acquired on June 30, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 20:29 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
SaleCommon Stock | 5,000 | $160.00 | $800,000.00 |
DisclosureSEC source: 0001127602-17-024873 · form4.xml · nonDerivative · entry 1 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,622.2577 F1 · balance_after: Amount includes 20.0268 shares acquired on June 30, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 20:22 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
SaleCommon Stock | 5,968 | $159.46 | $951,671.60 |
DisclosureSEC source: 0001127602-17-024870 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,122 Read SEC document |
| June 16, 2017 Filed Jun 19, 2017 18:48 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-021694 · form4.xml · derivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,361 Underlying: Common Stock · 4,050 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on 6/16/2015 and are now fully vested. F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on 6/16/2015 and are now fully vested. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| June 16, 2017 Filed Jun 19, 2017 18:48 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Tax withholdingCommon Stock | 1,926 | $140.77 | $271,123.02 |
DisclosureSEC source: 0001127602-17-021694 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,090 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| June 16, 2017 Filed Jun 19, 2017 18:48 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Exercise / conversionCommon Stock | 4,050 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-021694 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| May 22, 2017 Filed May 24, 2017 15:25 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
SaleCommon Stock | 3,613 | $139.84 | $505,258.90 |
DisclosureSEC source: 0001127602-17-019252 · form4.xml · nonDerivative · entry 1 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,789 Read SEC document |
| May 09, 2017 Filed May 11, 2017 12:17 UTC |
BELINGARD JEAN-LUCDirector
|
Exercise / conversionNon-qualified Stock Options · Derivative | 992 | $0.00 Strike: $77.58 | $0.00 |
DisclosureSEC source: 0001127602-17-017628 · form4.xml · derivative · entry 3 BELINGARD JEAN-LUC · CIK 0001200845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 992 shares Expires 2017-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2000 Stock Incentive Plan. F2 · derivative.exercise_date: The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable. Read SEC document |
| May 09, 2017 Filed May 11, 2017 12:17 UTC |
BELINGARD JEAN-LUCDirector
|
SaleCommon Stock | 992 | $142.19 | $141,052.48 |
DisclosureSEC source: 0001127602-17-017628 · form4.xml · nonDerivative · entry 2 BELINGARD JEAN-LUC · CIK 0001200845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,943 Read SEC document |
| May 09, 2017 Filed May 11, 2017 12:17 UTC |
BELINGARD JEAN-LUCDirector
|
Exercise / conversionCommon Stock | 992 | $77.58 | $76,959.36 |
DisclosureSEC source: 0001127602-17-017628 · form4.xml · nonDerivative · entry 1 BELINGARD JEAN-LUC · CIK 0001200845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2017 Filed Apr 6, 2017 13:55 UTC |
Gary M. HuffCEO, LabCorp Diagnostics
|
GrantRestricted Stock Unit · Derivative | 10,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-014419 · form4.xml · derivative · entry 2 Gary M. Huff · CIK 0001702387 · CEO, LabCorp Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,190 Underlying: Common Stock · 10,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 4/4/18. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 4/4/18. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| April 04, 2017 Filed Apr 6, 2017 13:55 UTC |
Gary M. HuffCEO, LabCorp Diagnostics
|
GrantRestricted Stock Unit · Derivative | 1,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-014419 · form4.xml · derivative · entry 1 Gary M. Huff · CIK 0001702387 · CEO, LabCorp Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,690 Underlying: Common Stock · 1,890 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18. F2 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 17:50 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Tax withholdingCommon Stock | 3,142 | $143.19 | $449,902.98 |
DisclosureSEC source: 0001127602-17-013374 · form4.xml · nonDerivative · entry 2 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,402 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 17:50 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
GrantCommon Stock | 6,755 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-013374 · form4.xml · nonDerivative · entry 1 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,544 F1 · kind: Shares acquired on March 29, 2017, pursuant to a performance award granted on February 11, 2014, relating to performance during the three-year period ended December 31, 2016. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 17:49 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 2,850 | $143.19 | $408,091.50 |
DisclosureSEC source: 0001127602-17-013373 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,753.5849 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 17:49 UTC |
Dodson Edward TPrincipal Accounting Officer
|
GrantCommon Stock | 6,755 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-013373 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,603.5849 F1 · kind: Shares acquired on March 29, 2017, pursuant to a performance award granted on February 11, 2014, relating to performance during the three-year period ended December 31, 2016. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 17:48 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Tax withholdingCommon Stock | 3,212 | $143.19 | $459,926.28 |
DisclosureSEC source: 0001127602-17-013372 · form4.xml · nonDerivative · entry 2 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,694 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 17:48 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
GrantCommon Stock | 7,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-013372 · form4.xml · nonDerivative · entry 1 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,906 F1 · kind: Shares acquired on March 29, 2017, pursuant to a performance award granted on February 11, 2014, relating to performance during the three-year period ended December 31, 2016. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 17:47 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Tax withholdingCommon Stock | 9,753 | $143.19 | $1,396,532.07 |
DisclosureSEC source: 0001127602-17-013371 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,966 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 17:47 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
GrantCommon Stock | 20,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-013371 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,719 F1 · kind: Shares acquired on March 29, 2017, pursuant to a performance award granted on February 11, 2014, relating to performance during the three-year period ended December 31, 2016. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 17:45 UTC |
KING DAVID PDirector · President & CEO
|
Tax withholdingCommon Stock | 48,596 | $143.19 | $6,958,461.24 |
DisclosureSEC source: 0001127602-17-013370 · form4.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,358.6154 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 17:45 UTC |
KING DAVID PDirector · President & CEO
|
GrantCommon Stock | 102,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-013370 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,954.6154 F1 · kind: Shares acquired on March 29, 2017, pursuant to a performance award granted on February 11, 2014, relating to performance during the three-year period ended December 31, 2016. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 19:17 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Tax withholdingCommon Stock | 201 | $144.24 | $28,992.24 |
DisclosureSEC source: 0001127602-17-011561 · form4.xml · nonDerivative · entry 4 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,602.2309 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 19:17 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Tax withholdingCommon Stock | 3,453 | $144.24 | $498,060.72 |
DisclosureSEC source: 0001127602-17-011561 · form4.xml · nonDerivative · entry 3 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,803.2309 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 18:52 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Tax withholdingCommon Stock | 132 | $144.24 | $19,039.68 |
DisclosureSEC source: 0001127602-17-011541 · form4.xml · nonDerivative · entry 2 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,789 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 18:44 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 149 | $144.24 | $21,491.76 |
DisclosureSEC source: 0001127602-17-011537 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,848.5849 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 18:43 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Tax withholdingCommon Stock | 153 | $144.24 | $22,068.72 |
DisclosureSEC source: 0001127602-17-011536 · form4.xml · nonDerivative · entry 2 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,136 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 18:41 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Tax withholdingCommon Stock | 774 | $144.24 | $111,641.76 |
DisclosureSEC source: 0001127602-17-011534 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,209 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 18:39 UTC |
KING DAVID PDirector · President & CEO
|
Tax withholdingCommon Stock | 2,890 | $144.24 | $416,853.60 |
DisclosureSEC source: 0001127602-17-011533 · form4.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,754.6154 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 11, 2017 Filed Mar 14, 2017 19:17 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 537 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-011561 · form4.xml · derivative · entry 6 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,724 Underlying: Common Stock · 537 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 3/11/2016. F5 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 3/11/2016. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| March 11, 2017 Filed Mar 14, 2017 19:17 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-011561 · form4.xml · derivative · entry 5 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,261 Underlying: Common Stock · 7,680 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Unit vested in two equal installments beginning on 3/11/2016 and are now fully vested. F3 · derivative.expiration_date: The Restricted Stock Unit vested in two equal installments beginning on 3/11/2016 and are now fully vested. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| March 11, 2017 Filed Mar 14, 2017 19:17 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Exercise / conversionCommon Stock | 537 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-011561 · form4.xml · nonDerivative · entry 2 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,256.2309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| March 11, 2017 Filed Mar 14, 2017 19:17 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Exercise / conversionCommon Stock | 7,680 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-011561 · form4.xml · nonDerivative · entry 1 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,719.2309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| March 11, 2017 Filed Mar 14, 2017 18:52 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-011541 · form4.xml · derivative · entry 3 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,284 Underlying: Common Stock · 400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 3/11/16. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 3/11/16. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| March 11, 2017 Filed Mar 14, 2017 18:52 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Exercise / conversionCommon Stock | 400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-011541 · form4.xml · nonDerivative · entry 1 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,921 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| March 11, 2017 Filed Mar 14, 2017 18:44 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-011537 · form4.xml · derivative · entry 3 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,040 Underlying: Common Stock · 400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 3/11/16. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 3/11/16. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| March 11, 2017 Filed Mar 14, 2017 18:44 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-011537 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,997.5849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| March 11, 2017 Filed Mar 14, 2017 18:43 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Exercise / conversionRestricted Stock Unit · Derivative | 463 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-011536 · form4.xml · derivative · entry 3 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,394 Underlying: Common Stock · 463 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 3/11/2016. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 3/11/2016. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| March 11, 2017 Filed Mar 14, 2017 18:43 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 463 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-011536 · form4.xml · nonDerivative · entry 1 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,289 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| March 11, 2017 Filed Mar 14, 2017 18:41 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,627 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-011534 · form4.xml · derivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,411 Underlying: Common Stock · 1,627 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 3/11/2016. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 3/11/2016. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| March 11, 2017 Filed Mar 14, 2017 18:41 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Exercise / conversionCommon Stock | 1,627 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-011534 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,983 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| March 11, 2017 Filed Mar 14, 2017 18:39 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-011533 · form4.xml · derivative · entry 6 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,824 Underlying: Common Stock · 6,077 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 3/11/2016. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 3/11/2016. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| March 11, 2017 Filed Mar 14, 2017 18:39 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionCommon Stock | 6,077 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-011533 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,644.6154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| March 09, 2017 Filed Mar 13, 2017 13:34 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
SaleCommon Stock | 2,200 | $142.47 | $313,444.12 |
DisclosureSEC source: 0001127602-17-011332 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,356 Read SEC document |
| March 09, 2017 Filed Mar 13, 2017 13:34 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
SaleCommon Stock | 100 | $142.46 | $14,245.70 |
DisclosureSEC source: 0001127602-17-011332 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,556 Read SEC document |
| February 24, 2017 Filed Feb 27, 2017 19:40 UTC |
MITTELSTAEDT ROBERT E JRDirector
|
Exercise / conversionNon-qualified Stock Options · Derivative | 5,300 | $0.00 Strike: $75.63 | $0.00 |
DisclosureSEC source: 0001127602-17-008540 · form4.xml · derivative · entry 7 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,300 shares Expires 2018-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Director stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan. F2 · derivative.exercise_date: The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.